In a harsh warning letter, the FDA has reprimanded Sanofi-Aventis for failing to meet regulatory deadlines for reporting serious side effects with many of its drugs, including the Lovenox blood thinner, the Multaq heart drug and the Allegra D allergy pill, and also did not report post-marketing studies or completed, unpublished clinical trials in NDA annual reports.
Read article at pharmalot.com
Friday, February 25, 2011
Sanofi Failed To Report Side Effects
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";